The inclusion targets the brain-gut axis, which is the communication pathway between the central nervous system and the enteric nervous system of the gut
Common Mild Side Effects Injection site discomfort or mild bruising Mild headache or nausea, typically resolving within a few hours Temporary skin sensitivity in some patients Gastrointestinal discomfort - more common with oral formulations than IV Rare but Serious Risks Allergic reactions: In rare cases, patients may experience urticaria (hives), angioedema, or - in very rare instances - anaphylaxis
Galimberti D, Vila Echague A, Ko EA, Pieri L, Comito A, Fusco I, et al
It does not provide the pronounced fullness or appetite suppression seen with GLP-1 therapies, but it plays a valuable role in reducing compulsive or emotional eating patterns